Accessibility Menu
 
MannKind logo

MannKind

(NASDAQ) MNKD

Current Price$2.48
Market Cap$761.01M
Since IPO (2004)-96%
5 Year-34%
1 Year-53%
1 Month-55%

MannKind Financials at a Glance

Market Cap

$761.01M

Revenue (TTM)

$348.97M

Net Income (TTM)

$5.86M

EPS (TTM)

$0.02

P/E Ratio

146.15

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$2.48

Volume

250,770

Open

$2.52

Previous Close

$2.48

Daily Range

$2.42 - $2.52

52-Week Range

$2.41 - $6.51

MNKD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MannKind

Industry

Biotechnology

Employees

592

CEO

Michael E. Castagna, MBA

Headquarters

Danbury, CA 91362, US

MNKD Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

11%

Net Income Margin

2%

Return on Equity

0%

Return on Capital

6%

Return on Assets

1%

Earnings Yield

0.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$761.01M

Shares Outstanding

308.10M

Volume

250.77K

Short Interest

0.00%

Avg. Volume

5.36M

Financials (TTM)

Gross Profit

$287.81M

Operating Income

$38.80M

EBITDA

$27.52M

Operating Cash Flow

$18.25M

Capital Expenditure

$4.57M

Free Cash Flow

$13.69M

Cash & ST Invst.

$171.35M

Total Debt

$473.38M

MannKind Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$111.95M

+45.8%

Gross Profit

$87.83M

+53.6%

Gross Margin

78.45%

N/A

Market Cap

$761.01M

N/A

Market Cap/Employee

$1.89M

N/A

Employees

403

N/A

Net Income

$15.95M

-314.9%

EBITDA

$2.51M

-113.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$302.04M

-854.4%

Accounts Receivable

$38.37M

+225.0%

Inventory

$35.31M

+26.6%

Long Term Debt

$424.14M

+194.3%

Short Term Debt

$49.24M

+275.2%

Return on Assets

0.74%

N/A

Return on Invested Capital

6.23%

N/A

Free Cash Flow

$9.95M

-150.4%

Operating Cash Flow

$7.96M

-135.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
JANXJanux Therapeutics, Inc.
$14.06-0.71%
BHVNBiohaven Ltd.
$8.93-0.33%
ABCLAbCellera Biologics Inc.
$3.40-3.68%
NUVBNuvation Bio Inc.
$4.22-0.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About MNKD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.